Within the field of biologics, the majority of R &D is currently focused on recombinant proteins and monoclonal antibodies (mAbs). The top three selling drugs are all mAbs. A total of over 40 antibody products and derivatives have been approved by EMA and FDA so far. Today, more than 400 antibodies, primarily involving immunological and oncological targets, are under pre-clinical development and clinical trials. Tosoh Bioscience offers a variety of (U)HPLC columns for mAb analysis and TOYOPEARL and TSKgel media for purification of antibody related products.